Briacell Therapeutics CORP. (BCTXZ) — S-1 Filings
All S-1 filings from Briacell Therapeutics CORP.. Browse 3 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (3)
-
BriaCell Launches Unit Offering Amidst Positive Clinical Trial Momentum
— Dec 23, 2025 Risk: high
BriaCell Therapeutics Corp. (BCTXZ) is conducting a best efforts offering of up to 2,793,296 Common Units, each consisting of one common share and one warrant, -
BriaCell Files S-1 for Continuous Offering, Signaling Capital Raise
— Jul 8, 2025 Risk: high
BriaCell Therapeutics Corp. (BCTXZ) filed an S-1 registration statement on July 8, 2025, for a proposed sale of securities on a delayed or continuous basis, ind -
BriaCell Therapeutics Files S-1 for Potential Offering
— Apr 22, 2025 Risk: medium
BriaCell Therapeutics Corp. filed an S-1 registration statement on April 22, 2025, for an unspecified offering. The company, formerly known as Ansell Capital Co
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX